Friday, March 29, 2024
Home Tags AnaptysBio

Tag: AnaptysBio

European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or...

0
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under Clinical Development, to...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News